azathioprine has been researched along with 2019 Novel Coronavirus Disease in 27 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 77-year-old patient with ulcerative colitis (UC) was transferred to our department because of worsening bloody diarrhea and abdominal pain, which was consistent with a UC flare." | 5.91 | An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine. ( Hirayama, D; Ishigami, K; Kazama, T; Nakase, H; Ohwada, S; Yamakawa, T; Yamano, HO; Yoshii, S, 2023) |
| "A VKH disease patient, well controlled on azathioprine therapy, presented a uveitis relapse eleven days after the first vaccination for COVID-19." | 4.12 | Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination. ( Accorinti, M; Manni, P; Saturno, MC, 2022) |
| " A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted with chief complaints of fever, chills, malaise, myalgia, and dyspnea." | 3.96 | COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? ( Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V, 2020) |
| "Only few cases of vaccine-induced immune thrombocytopenia or immune hemolysis have been reported so far." | 3.01 | Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review. ( Cvetković, M; Mitrović, M; Pantić, N; Pravdić, Z; Sabljić, N; Suvajdžić-Vuković, N; Virijević, M, 2023) |
| " However, the effects of glucocorticoids, methotrexate, TNF inhibitors and JAK inhibitors on vaccine responses remain unclear and could depend on the dosage and type of vaccination." | 3.01 | Effect of DMARDs on the immunogenicity of vaccines. ( Brouwer, E; Huckriede, ALW; van Baarle, D; van der Geest, KSM; van Sleen, Y, 2023) |
| "Achondroplasia is the commonest skeletal dysplasia of autosomal dominant inheritance caused by "gain of function" mutations in the fibroblast growth factor receptor 3 (FGFR3) gene." | 2.82 | Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update. ( Afshari, FT; Debenham, P; Parida, A; Solanki, GA, 2022) |
| "A 77-year-old patient with ulcerative colitis (UC) was transferred to our department because of worsening bloody diarrhea and abdominal pain, which was consistent with a UC flare." | 1.91 | An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine. ( Hirayama, D; Ishigami, K; Kazama, T; Nakase, H; Ohwada, S; Yamakawa, T; Yamano, HO; Yoshii, S, 2023) |
| "Ulcerative colitis was diagnosed 6 months earlier and treated with mesalamine 80 mg/kg/day and azathioprine 2." | 1.72 | SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report. ( Abbas, A; Alhalabi, M; Ali, F; Eddin, KA, 2022) |
| "The chronic use of immunosuppressive drugs is a key risk factor of death because of coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs), although no evident association between the class of immunosuppressive and outcomes has been observed." | 1.72 | The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19. ( Almeida, RAMB; Calazans, CAC; Charpiot, IMMF; Costa, KMAH; Cristelli, MP; de Lima, PR; de Sandes-Freitas, TV; Deboni, LM; Ferreira, GF; Ferreira, TCA; Garcia, VD; Manfro, RC; Mazzali, M; Medina-Pestana, J; Modelli de Andrade, LG; Nakamura, MR; Oriá, RB; Pacheco-Silva, A; Requião-Moura, LR; Simão, DR; Tedesco-Silva, H; Viana, LA, 2022) |
| " Additional goal was to evaluate adverse events of vaccination." | 1.72 | Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study. ( Coufal, S; Cupkova, A; Drabek, J; Hlava, S; Keil, R; Koptová, P; Kucerova, B; Milota, T; Pichlerová, D; Stovicek, J; Trojanek, M; Wasserbauer, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 27 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabaçam, G | 1 |
| Wahlin, S | 1 |
| Efe, C | 1 |
| Classen, JM | 1 |
| Muzalyova, A | 1 |
| Nagl, S | 1 |
| Fleischmann, C | 1 |
| Ebigbo, A | 1 |
| Römmele, C | 1 |
| Messmann, H | 1 |
| Schnoy, E | 1 |
| Alhalabi, M | 1 |
| Eddin, KA | 1 |
| Ali, F | 1 |
| Abbas, A | 1 |
| Accorinti, M | 1 |
| Saturno, MC | 1 |
| Manni, P | 1 |
| Li, J | 1 |
| Ayada, I | 1 |
| Wang, Y | 1 |
| den Hoed, CM | 1 |
| Kamar, N | 1 |
| Peppelenbosch, MP | 1 |
| de Vries, AC | 1 |
| Li, P | 1 |
| Pan, Q | 1 |
| Paybast, S | 1 |
| Emami, A | 1 |
| Baghalha, F | 1 |
| Naser Moghadasi, A | 1 |
| Requião-Moura, LR | 1 |
| Modelli de Andrade, LG | 1 |
| de Sandes-Freitas, TV | 1 |
| Cristelli, MP | 1 |
| Viana, LA | 1 |
| Nakamura, MR | 1 |
| Garcia, VD | 1 |
| Manfro, RC | 1 |
| Simão, DR | 1 |
| Almeida, RAMB | 1 |
| Ferreira, GF | 1 |
| Costa, KMAH | 1 |
| de Lima, PR | 1 |
| Pacheco-Silva, A | 1 |
| Charpiot, IMMF | 1 |
| Deboni, LM | 1 |
| Ferreira, TCA | 1 |
| Mazzali, M | 1 |
| Calazans, CAC | 1 |
| Oriá, RB | 1 |
| Tedesco-Silva, H | 1 |
| Medina-Pestana, J | 1 |
| den Otter, AAS | 1 |
| van der Houwen, TB | 1 |
| van Hagen, PM | 1 |
| van Laar, JAM | 1 |
| El Hasbani, G | 1 |
| Uthman, I | 1 |
| Afshari, FT | 1 |
| Parida, A | 1 |
| Debenham, P | 1 |
| Solanki, GA | 1 |
| Wasserbauer, M | 1 |
| Hlava, S | 1 |
| Trojanek, M | 1 |
| Stovicek, J | 1 |
| Milota, T | 1 |
| Drabek, J | 1 |
| Koptová, P | 1 |
| Cupkova, A | 1 |
| Pichlerová, D | 1 |
| Kucerova, B | 1 |
| Coufal, S | 1 |
| Keil, R | 1 |
| Choi, SY | 1 |
| Choi, S | 1 |
| Kang, B | 1 |
| Choe, BH | 1 |
| Lee, YJ | 1 |
| Park, JH | 1 |
| Kim, YB | 1 |
| Kim, JY | 1 |
| Lee, K | 1 |
| Lee, KJ | 1 |
| Kang, KS | 1 |
| Lee, YM | 1 |
| Kim, HJ | 1 |
| Kang, Y | 1 |
| Jang, HJ | 1 |
| Yi, DY | 1 |
| Hong, SJ | 1 |
| Choi, YJ | 1 |
| Hong, J | 1 |
| Kim, SC | 1 |
| Yamakawa, T | 3 |
| Ishigami, K | 3 |
| Ohwada, S | 3 |
| Kazama, T | 3 |
| Hirayama, D | 3 |
| Yoshii, S | 3 |
| Yamano, HO | 3 |
| Nakase, H | 3 |
| Barrett, R | 2 |
| Lin, SX | 1 |
| Culliford, D | 1 |
| Fraser, S | 1 |
| Edwards, CJ | 1 |
| Kridin, K | 1 |
| Mruwat, N | 1 |
| Amber, KT | 1 |
| Ludwig, RJ | 1 |
| Kim, S | 1 |
| Lee, EK | 1 |
| Sohn, E | 1 |
| Ueno, M | 1 |
| Takabatake, H | 1 |
| Itakura, J | 1 |
| Fujita, R | 1 |
| Kayahara, T | 1 |
| Morimoto, Y | 1 |
| Notohara, K | 1 |
| Mizuno, M | 1 |
| Cvetković, M | 1 |
| Pantić, N | 1 |
| Virijević, M | 1 |
| Pravdić, Z | 1 |
| Sabljić, N | 1 |
| Mitrović, M | 1 |
| Suvajdžić-Vuković, N | 1 |
| van Sleen, Y | 1 |
| van der Geest, KSM | 1 |
| Huckriede, ALW | 1 |
| van Baarle, D | 1 |
| Brouwer, E | 1 |
| Bozzalla Cassione, E | 1 |
| Zanframundo, G | 1 |
| Biglia, A | 1 |
| Codullo, V | 1 |
| Montecucco, C | 1 |
| Cavagna, L | 1 |
| Khan, N | 1 |
| Patel, D | 1 |
| Xie, D | 1 |
| Lewis, J | 1 |
| Trivedi, C | 1 |
| Yang, YX | 1 |
| Corrêa, DG | 1 |
| de Souza Lima, FC | 1 |
| da Cruz Bezerra, D | 1 |
| Coutinho, AC | 1 |
| Hygino da Cruz, LC | 1 |
| Ungaro, RC | 1 |
| Brenner, EJ | 1 |
| Gearry, RB | 1 |
| Kaplan, GG | 1 |
| Kissous-Hunt, M | 1 |
| Lewis, JD | 1 |
| Ng, SC | 1 |
| Rahier, JF | 1 |
| Reinisch, W | 1 |
| Steinwurz, F | 1 |
| Underwood, FE | 1 |
| Zhang, X | 1 |
| Colombel, JF | 1 |
| Kappelman, MD | 1 |
| Ahmadinejad, Z | 1 |
| Assari, R | 1 |
| Ayoobi Yazdi, N | 1 |
| Mazloomi, SH | 1 |
| Javanshayani, P | 1 |
| Khalili Afousi, H | 1 |
| Ziaee, V | 1 |
| Lees, CW | 1 |
| Irving, PM | 1 |
| Beaugerie, L | 1 |
| Reder, AT | 1 |
| Centonze, D | 1 |
| Naylor, ML | 1 |
| Nagpal, A | 1 |
| Rajbhandari, R | 1 |
| Altincatal, A | 1 |
| Kim, M | 1 |
| Berdofe, A | 1 |
| Radhakrishnan, M | 1 |
| Jung, E | 1 |
| Sandrock, AW | 1 |
| Smirnakis, K | 1 |
| Popescu, C | 1 |
| de Moor, C | 1 |
| Vuille-Lessard, É | 1 |
| Montani, M | 1 |
| Bosch, J | 1 |
| Semmo, N | 1 |
6 reviews available for azathioprine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis.
Topics: Antibodies, Viral; Azathioprine; Calcineurin Inhibitors; COVID-19; COVID-19 Vaccines; Humans; Immuno | 2022 |
Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
Topics: Aquaporin 4; Azathioprine; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Neoplasm | 2022 |
Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update.
Topics: Achondroplasia; Anesthetics; Azathioprine; Child; Constriction, Pathologic; COVID-19; Female; Humans | 2022 |
Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
Topics: Adrenal Cortex Hormones; Azathioprine; COVID-19; COVID-19 Vaccines; Female; Hepatitis, Autoimmune; H | 2023 |
Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Bilirubin; BNT162 Vaccine; Chronic Disease; COVID-19; C | 2023 |
Effect of DMARDs on the immunogenicity of vaccines.
Topics: Antirheumatic Agents; Azathioprine; COVID-19; Humans; SARS-CoV-2; Vaccination; Vaccines | 2023 |
21 other studies available for azathioprine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Autoimmune hepatitis triggered by COVID-19: A report of two cases.
Topics: Azathioprine; COVID-19; Hepatitis, Autoimmune; Humans; SARS-CoV-2 | 2021 |
Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
Topics: Aged; Antibody Formation; Azathioprine; Cohort Studies; COVID-19; COVID-19 Vaccines; Crohn Disease; | 2022 |
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report.
Topics: Adult; Azathioprine; Colitis, Ulcerative; COVID-19; COVID-19 Drug Treatment; Humans; Infliximab; Mal | 2022 |
Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Topics: Adrenal Cortex Hormones; Azathioprine; Chronic Disease; COVID-19; COVID-19 Vaccines; Female; Humans; | 2022 |
The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19.
Topics: Azathioprine; Calcineurin Inhibitors; COVID-19; Enzyme Inhibitors; Humans; Immunosuppressive Agents; | 2022 |
Clinical course of COVID-19 infections in patients with Behçet's disease in The Netherlands.
Topics: Adult; Azathioprine; Behcet Syndrome; COVID-19; Female; Humans; Male; Netherlands; Retrospective Stu | 2022 |
ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; BNT162 Vaccine; COVID-19; | 2023 |
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
Topics: Antibodies, Viral; Azathioprine; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Inflammatory B | 2022 |
Epidemiological Trends of Pediatric Inflammatory Bowel Disease in Korea: A Multicenter Study of the Last 3 Years Including the COVID-19 Era.
Topics: Azathioprine; Colitis, Ulcerative; COVID-19; Crohn Disease; Humans; Inflammatory Bowel Diseases; Inf | 2022 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; COVID-19; Female; Humans; Infliximab; Pneumonia; SARS-CoV-2 | 2023 |
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset.
Topics: Azathioprine; Communicable Disease Control; COVID-19; Drug Prescriptions; Humans; Hydroxychloroquine | 2022 |
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study.
Topics: Azathioprine; Cohort Studies; COVID-19; Cytomegalovirus Infections; Humans; Immunosuppressive Agents | 2023 |
Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Ad26COVS1; Aged; Azathioprine; COVID-19; COVID-19 Vaccines; Guillain-Ba | 2023 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study.
Topics: Adult; Aged; Azathioprine; Betacoronavirus; Coronavirus Infections; COVID-19; Gastrointestinal Agent | 2020 |
COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?
Topics: Aquaporin 4; Autoantibodies; Autoimmune Diseases; Azathioprine; Brain; COVID-19; Encephalomyelitis; | 2021 |
Effect of IBD medications on COVID-19 outcomes: results from an international registry.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; COVID-19; Drug Therapy, Combination; Female; Humans; | 2021 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Beta | 2020 |
COVID-19 and IBD drugs: should we change anything at the moment?
Topics: Azathioprine; COVID-19; Humans; Inflammatory Bowel Diseases; Infliximab; Pharmaceutical Preparations | 2021 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cl | 2021 |
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Autoantibodies; Azathioprine; Carcinoma, Transitional Cell; Causa | 2021 |